Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis [0.03%]
日本前列腺癌雄激素剥夺治疗的全国性流行病学调查及成本分析研究
Sosuke Omizo,Takuma Narita,Tomoko Hamaya et al.
Sosuke Omizo et al.
Objective: Anti-androgen therapy is central to prostate cancer management, but nationwide real-world trends in prescribing and costs remain insufficiently characterized in aging societies. We evaluated temporal trends in ...
Progress in siRNA nucleic acid therapeutics and challenges in their application to cancer treatment [0.03%]
siRNA核酸药物研究进展及其在癌症治疗中的挑战
Kumiko Ui-Tei
Kumiko Ui-Tei
Small interfering RNA (siRNA) therapeutics have emerged as a promising class of nucleic acid-based medicines that selectively suppress the expression of disease-associated genes by targeting messenger RNAs (mRNAs). Unlike conventional small...
Screening for prognostic indicators in patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibitor treatment for metastatic castration-sensitive prostate cancer [0.03%]
在转移性雄激素敏感型前列腺癌接受雄激素受体信号传导抑制剂治疗后,评估转移性去势抵抗型前列腺癌预后指标的筛选研究
Keita Hayakawa,Takashi Ueda,Yusuke Gabata et al.
Keita Hayakawa et al.
Background: Androgen receptor signaling inhibitors (ARSI) and docetaxel (DTX) are standard treatments for metastatic castration-resistant prostate cancer (mCRPC). However, the differences in therapeutic efficacy between t...
Impact of pre-existing schizophrenia spectrum disorder on the receipt of invasive and systemic therapy for gastric cancer: a multicenter nationwide cohort study in Japan [0.03%]
日本多中心全国队列研究:既有分裂症前期疾病对胃癌侵入性及全身治疗接受度的影响
Myo Min Khant,Masaki Fujiwara,Yuto Yamada et al.
Myo Min Khant et al.
Background: Patients with schizophrenia spectrum disorders (SSD) experience higher cancer mortality, partly because of later-stage diagnosis and lower rates of recommended treatments. While treatment disparities have been...
Takeshi Murata,Tomomi Fujisawa,Fumikata Hara et al.
Takeshi Murata et al.
Breast cancer treatment is rapidly evolving toward precision-based de-escalation strategies for oncological safety and minimizing treatment-related morbidity. In early stage disease, minimally invasive approaches, such as non-surgical ablat...
Immune effector cell-associated hematotoxicity following CAR-T cell therapies: insights from a large national database [0.03%]
CAR-T细胞治疗后的免疫效应细胞相关血液毒性:来自大型国家数据库的见解
Connor Frey
Connor Frey
Immune effector cell-associated hematotoxicity is a recognized but incompletely characterized complication of chimeric antigen receptor T-cell (CAR-T) therapy, defined by prolonged, severe, or recurrent cytopenias following CAR-T infusion, ...
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY) [0.03%]
每周一次卡铂放化疗与单纯放疗治疗老年低体能评分头颈部鳞癌患者的III期临床研究(JCOG2405,ELDER-WEEKLY)
Kota Kawabata,Koichi Yasuda,Satoaki Nakamura et al.
Kota Kawabata et al.
Chemoradiotherapy (CRT) with high-dose cisplatin (100 mg/m2) is the standard treatment for locally advanced squamous cell carcinoma of the head and neck (SCCHN). However, this regimen is often intolerable in elderly patients because of its ...
Hereditary cancer multigene panel testing in the United States and Europe: real-world constraints and implications for responsible integration in Japan [0.03%]
美国和欧洲的遗传性癌症多基因检测板检测及其在日本负责任整合的实际限制和意义
Issei Imoto,Nobue Takaiso,Akiyo Yoshimura et al.
Issei Imoto et al.
Multigene panel testing has become an important component of hereditary cancer evaluation in Western practice. This shift has been driven by advances in next-generation sequencing, declining costs, and the increasing relevance of germline f...
Current status and future perspectives of treatment de-escalation in localized head and neck cancer [0.03%]
局部头颈部癌症治疗减毒的现状与未来展望
Shinya Hiraoka,Takeshi Kodaira,Nobuhiro Hanai et al.
Shinya Hiraoka et al.
Head and neck squamous cell carcinoma (HNSCC) often requires invasive multimodal therapy, including surgery, radiotherapy, and chemotherapy. Although these interventions have improved treatment outcomes, patients frequently experience long-...